InvestorsHub Logo
Followers 17
Posts 308
Boards Moderated 0
Alias Born 02/23/2013

Re: bejamin post# 124027

Friday, 10/02/2015 9:34:24 AM

Friday, October 02, 2015 9:34:24 AM

Post# of 402976
Brilacidin, once all claims are vetted, represents a disruptive technology. As trials reveal more promise, I expect to see a sharp increase in attacks from competitors/special interests with obsolete platforms, which if Cellceutix can defend against, will be followed by a cascade of acquisition offers. (Oh yeah, I keep nearly forgetting we have two other drugs in trials as well)

[img]

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News